查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1532007

2024 年哺乳动物细胞发酵技术全球市场报告

Mammalian Cell Fermentation Technology Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

哺乳动物细胞发酵技术市场规模预计在未来几年将快速成长。 2028年，将以11.8%的年复合成长率（CAGR）成长至801.6亿美元。预测期内预期成长的因素包括慢性病盛行率增加、跨国公司投资增加、慢性病发生频率增加、先进生物加工技术的采用增加以及新的重组技术，其中包括对蛋白质研发的投资增加。的需求增加。这段时期的主要趋势包括细胞培养和反应器设计的技术进步、下一代生物加工技术的开发、多组体学方法的整合以及技术主导的自动化。

生技药品需求的增加预计将在未来几年推动哺乳动物细胞发酵技术市场的成长。生技药品是从活生物体或其成分中提取的药物，通常用于治疗癌症、自体免疫疾病和感染疾病等疾病。生物技术的进步、其治疗流行慢性病的有效性、监管部门的核准以及研发投资的增加推动了对生技药品的需求不断增长。哺乳动物细胞发酵技术对于製造复杂的生技药品和满足日益增长的个人化和标靶治疗的需求至关重要。其可扩展性、多功能性和生产高品质蛋白质的能力促进了生物製药行业的创新。例如，美国国家医学图书馆在 2024 年 2 月报告称，食品药物管理局(FDA) 将在 2023 年核准55 种新药，其中包括 29 种新化学实体 (NCE) 和 25 种新生物製药( NBE)。因此，对生技药品的需求不断增长正在推动哺乳动物细胞发酵技术市场的扩大。

哺乳动物细胞发酵技术市场的领先公司正在开发哺乳动物细胞培养等创新技术，以巩固其市场地位。哺乳动物细胞培养是生物製造、研究和再生医学的重要工具，能够生产治疗性蛋白质、疫苗以及功能性细胞和组织类似物。例如，2021年2月，美国生技公司Culture Biosciences宣布推出用于哺乳动物细胞培养的云生物反应器。这项突破性技术为可扩展的细胞培养研究提供了一个完整的云端基础的平台，是生物加工领域的重大进步。此云端反应器利用远端监控技术，可在任何有网路存取的地方实现即时资料分析和决策，为生物製程和生物製造开发提供扩充性、灵活性和增强协作。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球哺乳动物细胞发酵技术市场：驱动因素与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 全球哺乳动物细胞发酵技术市场表现：规模与成长，2018-2023
  • 全球哺乳动物细胞发酵技术市场预测：规模与成长，2023-2028，2033F

第六章 市场细分

  • 全球哺乳动物细胞发酵技术市场：按类型分類的表现与预测，2018-2023、2023-2028F、2033F
  • 中国仓鼠卵巢细胞发酵
  • 人类胎肾细胞发酵
  • 小仓鼠肾细胞发酵
  • 小鼠骨髓瘤细胞的发酵
  • 其他类型
  • 全球哺乳动物细胞发酵技术市场：按应用分類的表现与预测，2018-2023、2023-2028F、2033F
  • 单株抗体
  • 重组蛋白
  • 疫苗
  • 荷尔蒙
  • 酵素
  • 其他用途
  • 全球哺乳动物细胞发酵技术市场：依最终用途分類的表现与预测，2018-2023、2023-2028F、2033F
  • 生物製药公司
  • 合约研究组织和合约开发製造组织
  • 学术研究所

第 7 章 区域/国家分析

  • 全球哺乳动物细胞发酵技术市场：按地区分類的表现与预测，2018-2023、2023-2028F、2033F
  • 全球哺乳动物细胞发酵技术市场：按国家分類的表现和预测，2018-2023、2023-2028F、2033F

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争格局及公司概况

  • 哺乳动物细胞发酵技术市场：竞争格局
  • 哺乳动物细胞发酵技术市场：公司简介
    • AbbVie Inc.
    • Thermo Fisher Scientific Inc
    • AstraZeneca PLC
    • Roche Holdings Inc.
    • Merck KGaA

第三十一章 其他重大及创新企业

  • AGC Group
  • Lonza Group Ltd.
  • Boehringer Ingelheim GmbH
  • Catalent Inc.
  • Sartorius AG
  • Samsung Biologics Co. Ltd.
  • WuXi Biologics
  • Biocon Limited
  • Eppendorf AG
  • KBI Biopharma Inc.
  • Fujifilm Diosynth Biotechnologies
  • Avid Bioservices Inc.
  • BiOZEEN
  • Nordmark Pharma GmbH
  • Scorpius BioManufacturing Inc.

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章前瞻性与潜力分析

第36章附录

简介目录
Product Code: r18916

Mammalian cell fermentation technology refers to the process of cultivating mammalian cells under controlled conditions to produce biopharmaceuticals, vaccines, or other biological products. This technology involves optimizing cell growth and protein expression in bioreactors or fermenters, ensuring the production of high-quality and consistent yields of desired therapeutic proteins or substances.

The main types of mammalian cell fermentation technology include Chinese hamster ovary (CHO) cell fermentation, human embryonic kidney (HEK) cell fermentation, baby hamster kidney (BHK) cell fermentation, murine myeloma cell fermentation, and other types. Chinese hamster ovary (CHO) cell fermentation is a biotechnological process used in the production of therapeutic proteins, such as monoclonal antibodies and recombinant proteins. The various applications of mammalian cell fermentation technology include monoclonal antibodies, recombinant proteins, vaccines, hormones, enzymes, and other products. The end-users of this technology include biopharmaceutical companies, contract research organizations (CROs), contract development and manufacturing organizations (CDMOs), and academic and research institutes.

The mammalian cell fermentation technology market research report is one of a series of new reports from The Business Research Company that provides mammalian cell fermentation technology market statistics, including mammalian cell fermentation technology industry global market size, regional shares, competitors with a mammalian cell fermentation technology market share, detailed mammalian cell fermentation technology market segments, market trends, and opportunities, and any further data you may need to thrive in the mammalian cell fermentation technology industry. This mammalian cell fermentation technology research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The mammalian cell fermentation technology market size has grown rapidly in recent years. It will grow from $46.05 billion in 2023 to $51.29 billion in 2024 at a compound annual growth rate (CAGR) of 11.4%. The growth observed in the historic period can be attributed to several factors, including increased demand for biologics and biosimilars, a heightened focus on personalized medicine, an increased output of biopharmaceuticals, and a rising demand for scalable and effective cell culture methods.

The mammalian cell fermentation technology market size is expected to see rapid growth in the next few years. It will grow to $80.16 billion in 2028 at a compound annual growth rate (CAGR) of 11.8%. The expected growth in the forecast period can be attributed to several factors, including the increasing prevalence of chronic diseases, rising investments by multinational corporations, the growing frequency of chronic diseases, the increasing adoption of advanced bioprocessing techniques, rising investment in research and development of novel recombinant proteins, and the growing demand for cancer therapies. Major trends anticipated during this period include technological advancements in cell culture and bioreactor design, the development of next-generation bioprocessing technologies, the integration of multi-omics approaches, and technology-driven automation.

The increasing demand for biologics is anticipated to drive the growth of the mammalian cell fermentation technology market in the future. Biologics, which are medical products derived from living organisms or their components, are often used to treat diseases such as cancer, autoimmune disorders, and infectious diseases. The growing demand for biologics is driven by advancements in biotechnology, their effectiveness in treating prevalent chronic diseases, regulatory approvals, and increased investment in research and development. Mammalian cell fermentation technology is crucial for producing complex biologics, meeting the rising demand for personalized and targeted therapeutics. Its scalability, versatility, and ability to produce high-quality proteins foster innovation in the biopharmaceutical industry. For example, the National Library of Medicine reported in February 2024 that the Food and Drug Administration (FDA) approved 55 new drugs in 2023, including 29 new chemical entities (NCEs) and 25 new biological entities (NBEs), marking a 50% increase compared to the 37 approvals in 2022. Therefore, the growing demand for biologics is driving the expansion of the mammalian cell fermentation technology market.

Leading companies in the mammalian cell fermentation technology market are developing innovative technologies, such as mammalian cell culture, to bolster their market position. Mammalian cell culture is a vital tool in biomanufacturing, research, and regenerative medicine, enabling the production of therapeutic proteins, vaccines, and functional cells or tissue analogs. For instance, in February 2021, Culture Bioscience, a US-based biotechnology company, introduced cloud bioreactors for mammalian cell culture. This groundbreaking technology provides a fully cloud-based platform for scalable cell culture research, representing a significant advancement in bioprocessing. These cloud bioreactors utilize remote monitoring and control technologies to offer real-time data analysis and decision-making from any location with internet access, enhancing scalability, flexibility, and collaboration in bioprocess and biomanufacturing development.

In February 2024, Chrysea Limited, an Ireland-based biotechnology company, acquired Rodon Biologics from the Iberfar Group for an undisclosed amount. With this acquisition, Chrysea aims to strengthen its synthetic biology and biopharmaceutical development capabilities by integrating Rodon Biologics' expertise in protein engineering, cell-line development, precision fermentation, downstream processing, formulation, analytics, and production. Rodon Biologics, a Portugal-based manufacturer of biological products, operates in mammalian cell fermentation technology.

Major companies operating in the mammalian cell fermentation technology market are AbbVie Inc., Thermo Fisher Scientific Inc, AstraZeneca PLC, Roche Holdings Inc., Merck KGaA, AGC Group, Lonza Group Ltd., Boehringer Ingelheim GmbH, Catalent Inc., Sartorius AG, Samsung Biologics Co. Ltd., WuXi Biologics, Biocon Limited, Eppendorf AG, KBI Biopharma Inc., Fujifilm Diosynth Biotechnologies, Avid Bioservices Inc., BiOZEEN, Nordmark Pharma GmbH, Scorpius BioManufacturing Inc

North America was the largest region in the mammalian cell fermentation technology market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mammalian cell fermentation technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the mammalian cell fermentation technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The mammalian cell fermentation technology market consists revenues earned by entities by providing services such as cell line development, process development, cell culture and fermentation, analytical and quality control services, and formulation and fill-finish services. The market value includes the value of related goods sold by the service provider or included within the service offering. The mammalian cell fermentation technology market also includes of sales of biosimilars, cell and gene therapy products, diagnostic enzymes and proteins, and therapeutic proteins. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Mammalian Cell Fermentation Technology Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on mammalian cell fermentation technology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for mammalian cell fermentation technology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The mammalian cell fermentation technology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Chinese Hamster Ovary Cell Fermentation; Human Embryonic Kidney Cell Fermentation; Baby Hamster Kidney Cell Fermentation; Murine Myeloma Cell Fermentation; Other Types
  • 2) By Application: Monoclonal Antibodies; Recombinant Proteins; Vaccines; Hormones; Enzymes; Other Applications
  • 3) By End-Use: Biopharmaceutical Companies; Contract Research Organizations And Contract Development and Manufacturing Organizations; Academic And Research Institutes
  • Companies Mentioned: AbbVie Inc.; Thermo Fisher Scientific Inc; AstraZeneca PLC; Roche Holdings Inc.; Merck KGaA
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Mammalian Cell Fermentation Technology Market Characteristics

3. Mammalian Cell Fermentation Technology Market Trends And Strategies

4. Mammalian Cell Fermentation Technology Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Mammalian Cell Fermentation Technology Market Size and Growth

  • 5.1. Global Mammalian Cell Fermentation Technology Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Mammalian Cell Fermentation Technology Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Mammalian Cell Fermentation Technology Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Mammalian Cell Fermentation Technology Market Segmentation

  • 6.1. Global Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Chinese Hamster Ovary Cell Fermentation
  • Human Embryonic Kidney Cell Fermentation
  • Baby Hamster Kidney Cell Fermentation
  • Murine Myeloma Cell Fermentation
  • Other Types
  • 6.2. Global Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Monoclonal Antibodies
  • Recombinant Proteins
  • Vaccines
  • Hormones
  • Enzymes
  • Other Applications
  • 6.3. Global Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Biopharmaceutical Companies
  • Contract Research Organizations And Contract Development and Manufacturing Organizations
  • Academic And Research Institutes

7. Mammalian Cell Fermentation Technology Market Regional And Country Analysis

  • 7.1. Global Mammalian Cell Fermentation Technology Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Mammalian Cell Fermentation Technology Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Mammalian Cell Fermentation Technology Market

  • 8.1. Asia-Pacific Mammalian Cell Fermentation Technology Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Mammalian Cell Fermentation Technology Market

  • 9.1. China Mammalian Cell Fermentation Technology Market Overview
  • 9.2. China Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Mammalian Cell Fermentation Technology Market

  • 10.1. India Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Mammalian Cell Fermentation Technology Market

  • 11.1. Japan Mammalian Cell Fermentation Technology Market Overview
  • 11.2. Japan Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Mammalian Cell Fermentation Technology Market

  • 12.1. Australia Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Mammalian Cell Fermentation Technology Market

  • 13.1. Indonesia Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Mammalian Cell Fermentation Technology Market

  • 14.1. South Korea Mammalian Cell Fermentation Technology Market Overview
  • 14.2. South Korea Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Mammalian Cell Fermentation Technology Market

  • 15.1. Western Europe Mammalian Cell Fermentation Technology Market Overview
  • 15.2. Western Europe Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Mammalian Cell Fermentation Technology Market

  • 16.1. UK Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Mammalian Cell Fermentation Technology Market

  • 17.1. Germany Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Mammalian Cell Fermentation Technology Market

  • 18.1. France Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Mammalian Cell Fermentation Technology Market

  • 19.1. Italy Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Mammalian Cell Fermentation Technology Market

  • 20.1. Spain Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Mammalian Cell Fermentation Technology Market

  • 21.1. Eastern Europe Mammalian Cell Fermentation Technology Market Overview
  • 21.2. Eastern Europe Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Mammalian Cell Fermentation Technology Market

  • 22.1. Russia Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Mammalian Cell Fermentation Technology Market

  • 23.1. North America Mammalian Cell Fermentation Technology Market Overview
  • 23.2. North America Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Mammalian Cell Fermentation Technology Market

  • 24.1. USA Mammalian Cell Fermentation Technology Market Overview
  • 24.2. USA Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Mammalian Cell Fermentation Technology Market

  • 25.1. Canada Mammalian Cell Fermentation Technology Market Overview
  • 25.2. Canada Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Mammalian Cell Fermentation Technology Market

  • 26.1. South America Mammalian Cell Fermentation Technology Market Overview
  • 26.2. South America Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Mammalian Cell Fermentation Technology Market

  • 27.1. Brazil Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Mammalian Cell Fermentation Technology Market

  • 28.1. Middle East Mammalian Cell Fermentation Technology Market Overview
  • 28.2. Middle East Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Mammalian Cell Fermentation Technology Market

  • 29.1. Africa Mammalian Cell Fermentation Technology Market Overview
  • 29.2. Africa Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Mammalian Cell Fermentation Technology Market Competitive Landscape And Company Profiles

  • 30.1. Mammalian Cell Fermentation Technology Market Competitive Landscape
  • 30.2. Mammalian Cell Fermentation Technology Market Company Profiles
    • 30.2.1. AbbVie Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Thermo Fisher Scientific Inc
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. AstraZeneca PLC
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Roche Holdings Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Merck KGaA
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Mammalian Cell Fermentation Technology Market Other Major And Innovative Companies

  • 31.1. AGC Group
  • 31.2. Lonza Group Ltd.
  • 31.3. Boehringer Ingelheim GmbH
  • 31.4. Catalent Inc.
  • 31.5. Sartorius AG
  • 31.6. Samsung Biologics Co. Ltd.
  • 31.7. WuXi Biologics
  • 31.8. Biocon Limited
  • 31.9. Eppendorf AG
  • 31.10. KBI Biopharma Inc.
  • 31.11. Fujifilm Diosynth Biotechnologies
  • 31.12. Avid Bioservices Inc.
  • 31.13. BiOZEEN
  • 31.14. Nordmark Pharma GmbH
  • 31.15. Scorpius BioManufacturing Inc.

32. Global Mammalian Cell Fermentation Technology Market Competitive Benchmarking

33. Global Mammalian Cell Fermentation Technology Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Mammalian Cell Fermentation Technology Market

35. Mammalian Cell Fermentation Technology Market Future Outlook and Potential Analysis

  • 35.1 Mammalian Cell Fermentation Technology Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Mammalian Cell Fermentation Technology Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Mammalian Cell Fermentation Technology Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer